cervical cancer
FDA Approves First-Line Keytruda Combo for PD-L1-Expressing Cervical Cancer Patients
The agency approved Keytruda as a front-line option with chemo, with or without Avastin, and converted a second-line accelerated approval for the immunotherapy to full approval.
European Consortium Wins €6.9M Grant to Develop HPV16-Positive Cancer Vaccine
The consortium, led by a Belgium biotech, will use the funds to advance an mRNA-based vaccine as a treatment for head and neck, cervical, and anogenital cancers.
Qiagen, Inovio Expand CDx Partnership, Starting With NGS Test for Cervical Dysplasia Therapy
The partners will develop a test to identify women most likely to benefit from VGX-3100, Inovio's immunotherapy to treat HPV-associated advanced cervical dysplasia.
Treating patients with their own lymphocytes has been tricky to define as a product from the commercial perspective, but a forthcoming approval may change that. Â
Wales to Routinely Screen Cancer Patients With Yourgene Elucigene Test
Yourgene will provide its Elucigene DPYD tests to screen approximately 200 patients each month for the next year.